China Shineway Pharmaceutical Group Limited China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited

2877

Rang in Aktien #10954
As an investment holding enterprise, China Shineway Pharmaceutical Group... As an investment holding enterprise, China Shineway Pharmaceutical Group Limited is dedicated to the development, production, and sale of traditional Chinese medicines throughout the People's Republic of China and Hong Kong. Its extensive product range includes modern Chinese pharmaceuticals delivered as soft capsules, granular preparations, and injectable forms, alongside specialized Traditional Chinese Medicine (TCM) Formula Granules. These offerings cater to a broad spectrum of therapeutic needs, such as cardiovascular and cerebrovascular health, anti-viral applications, orthopedic conditions, pediatric ailments, gynecological care, and gastrointestinal issues. Furthermore, the company is involved in the trading of agricultural commodities. Founded in 2004, its headquarters are situated in Shijiazhuang, PRC, and it functions as a subsidiary of Forway Investment Limited.
Aktienkurs
$0.95816746
Marktkapitalisierung
$723.80M
Veränderung (1 Tag)
0.67%
Veränderung (1 Jahr)
-95.02%
Land
CN
Handel China Shineway Pharmaceutical Group Limited (2877)

Kategorie

Healthcare
Dividendenhistorie für China Shineway Pharmaceutical Group Limited (2877)
China Shineway Pharmaceutical Group Limited (Aktienkürzel: 2877) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für China Shineway Pharmaceutical Group Limited (2877) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber